HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog
Updated on: March 04,2026
HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog
Updated on:March 04,2026
